BioCentury
ARTICLE | Deals

Fresh off Everest’s Hong Kong debut, CBC planning IPO for newly merged portfolio companies

AffaMed, EverInsight will focus on ophthalmology, neurology and psychiatry drugs 

October 16, 2020 1:32 AM UTC

Two newly merged companies backed by CBC are already looking ahead to an IPO, a week after a high-profile debut by another of the Asian investment firm’s portfolio companies. The combination of ...



Access this Article